Login
$RPRX
$65.28 +$0.52 (0.8%) Close

Company Executives

$RPRX Management Team

Mr. Pablo Legorreta

Chairman of the Board

Chief Executive Officer

Age 61
Compensation $49.51M USD
Sex Male

Mr. Christopher Hite

Vice Chairman

Executive Vice President

Age 58
Compensation $1.260M USD
Sex Male

Mr. Terrance Coyne

Chief Financial Officer

Executive Vice President

Age 43
Compensation $1.260M USD
Sex Male

Mr. George Lloyd

Executive Vice President - Investments & Chief Legal Officer

Age 66
Compensation $1.260M USD
Sex Male

Dr. Marshall Urist

Executive Vice President - Research & Investments

Age 49
Compensation $1.260M USD
Sex Male
Directors
10
serving now
Independent
9 of 9
stated in the proxy; 1 not stated
Average tenure
4.1 years
from year joined
CEO also chairs the board
Yes
Pablo Legorreta
Director Age On board Independent Committees Other public boards 2025 pay Source
Pablo Legorreta
62 2020
6 years
Not stated None stated ProKidney Corp. Paid as CEO
Ted Love
67 2020
6 years
Independent None stated Structure Therapeutics Inc. Not stated
Bonnie Bassler
63 2020
6 years
Independent None stated Regeneron Pharmaceuticals, Inc. Not stated
Vlad Coric
55 2025
1 year
Independent None stated Biohaven Limited $462,000
Catherine Engelbert
61 2020
6 years
Independent None stated McDonald’s Corporation Not stated
Carole Ho
53 2025
1 year
Independent None stated None stated $383,005
David Hodgson
69 2022
4 years
Independent
Audit Committee
TriNet Group, Inc. Not stated
Gregory Norden
68 2020
6 years
Independent
Audit Committee · Chair
Zoetis Inc. Not stated
Elizabeth Weatherman
66 2025
1 year
Independent None stated Insulet Corp. $383,005
Errol De Souza
Not stated Not stated Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

5 disclosed in the proxy filed Apr 10, 2026
named executive officers
officers of RP Management, LLC (RPM) at the time of the Transaction
Amount not stated

Internalization: named executive officers were officers of RPM, the external manager acquired by the Company, and were entitled to a portion of the Cash Consideration and Share Consideration

With RPM Open in proxy
named executive officers
officers of RP Management, LLC (RPM) at the time of the Transaction
Amount not stated

Employment offer letter arrangements entered into by each named executive officer in connection with the closing of the Internalization

With Royalty Pharma Open in proxy
Mr. Legorreta
owner of and controlling member of entities that receive Equity Performance Awards
Amount not stated

Entities owned and controlled by Mr. Legorreta receive Equity Performance Awards, and he determines their allocation

directors and named executive officers
directors and named executive officers of the Company
Amount not stated

Unlimited piggyback registration rights granted to directors and named executive officers

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support